References
- Bonnadonna , G , Brusamolino , E Valagussa , P . 1976 . Combination chemotherapy as an adjuvant treatment in operable breast cancer . N Engl Med , 294 : 405 – 410 .
- Fisher , B , Carbone , P Economou , SQ . 1975 . L‐phenyl‐alanine mustard (L‐PAM) in the management of primary breast cancer: Report of early findings . N Engl J Med , 292 : 117 – 122 .
- NIH Consensus Conference . 1985 . Adjuvant therapy for breast cancer . JAMA , 254 : 3461 – 3463 .
- Early Breast Cancer Trialists’ Collaborative Group . 1988 . Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer . New Engl J Med , 319 : 1681 – 1692 .
- Kennedy , BJ , Mielke , PW and Fortuny , IE . 1964 . Therapeutic castration versus prophylactic castration in breast cancer . Surg Gynecol Obstet , 118 : 524 – 540 .
- Gelber , RD , Goldhirsch , A Castiglione , M . 1987 . “ Time without symptoms and toxicity (TWIST): A quality‐of‐life‐oriental endpoint to evaluate adjuvant therapy ” . In Adjuvant Therapy of Cancer V. , Edited by: Salmon , SE . 455 – 465 . Orlando, FL : Grune and Stratton .
- Glick , JH . 1988 . Meeting highlights: Adjuvant therapy for breast cancer . J Nat Cancer Inst , 80 : 471 – 475 .
- Bonnadonna , G , Zambetti , M Valagussa , P . 1986 . Adjuvant CMF in node negative breast cancer . Proc Am Soc Clin Oncol , 5 : 74
- Bonnadonna , G , Valagussa , P Zambetti , M . 1987 . “ Milan adjuvant trials for stage I—II breast cancer ” . In Adjuvant Therapy of Cancer V. , Edited by: Salmon , SE . 211 – 222 . Orlando, FL : Grune and Stratton .
- American Joint Committee on Cancer . 1988 . “ Breast ” . In Manual for Staging of Cancer. , Edited by: Beahrs , O , Henson , DE , Hutter , RVP and Myers , MH . 145 – 150 . Philadelphia : J.B. Lippincott Co .
- News , Item . 1988 . J Nat Cancer Inst , 80 June 15 : 550 – 551 .
- Carter , CL , Allen , C and Henson , DE . 1989 . Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases . Cancer , 63 : 181 – 187 .
- Rosen , PP , Groshen , S Saigo , PE . 1989 . A long‐term follow‐up study of survival in stage I (T1,N0,M0) and stage II (T1N1M0) breast carcinoma . J Clin Onc , 7 : 355 – 366 .
- Statement in Response to the Clinical Alert from the National Cancer Institute . 1988 . Am Coll Surg Bull . 73 July : 17
- Wittes , RE . 1988 . Of clinical alerts and peer review . J Nat Cancer Inst , 80 September : 984 – 985 .
- Vanchieri , C . 1988 . News: Clinical alert stimulates changes in practice . J Nat Cancer Inst , 80 Oct 5 : 1185 – 1187 .
- Lee , KC . 1988 . The “Clinical Alert”; from the National Cancer Institute . N Engl J Med , 319 : 948 – 949 .
- 1988 . The Cancer Letter , 14 Nov. : 6 – 8 .
- Henderson , IC , McQuire , WL Glick , JH . 1988 . “ Adjuvant therapy in node‐negative breast cancer ” . In Oncology Viewpoints, , New York : L.P. Communications, Inc . special issue
- Fisher , B , Redmond , C and Dimitrov , NV . 1989 . A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node‐negative breast cancer who have estrogen receptor‐negative tumors . N Engl J Med , 320 : 473 – 478 .
- Fisher , B , Costantino , J and Redmond , C . 1989 . Randomized clinical trial evaluating tamoxifen in the treatment of patients with node‐negative breast cancer who have estrogen receptor‐positive tumors . N Engl J Med , 320 : 479 – 484 .
- Mansour , EG , Gray , R Shatila , AH . 1989 . Efficacy of adjuvant chemotherapy in high‐risk node‐negative breast cancer: An intergroup study . N Engl J Med , 320 : 485 – 490 .
- The Ludwig Breast Cancer Study Group . 1989 . Prolonged disease‐free survival after one course of perioperative adjuvant chemotherapy for node‐negative breast cancer . N Engl J Med , 320 : 491 – 495 .
- McGuire , WL . 1989 . Adjuvant therapy of node‐negative breast cancer . N Engl J Med , 320 : 525 – 527 .
- DeVita , VT Jr. 1989 . Breast cancer therapy: Exercising all our options . N Engl J Med , 320 : 527 – 529 .
- Regents' Professor of Medicine, Masonic Professor of Oncology, Director, Division of Oncology, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN.